BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo® (cemiplimab) Combination in NSCLC

Israel Lowy,

Press/Media

Period	8 Mar 2022 → 9 Mar 2022

Media coverage

19

Media coverage

Title	BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo® (cemiplimab) Combination in NSCLC
Media name/outlet	PharmiWeb
Country/Territory	United Kingdom
Date	9/03/22
URL	ct.moreover.com/?a=47217773106&p=1gw&v=1&x=QPOeJNYBbyptLTDZCMW-6A
Persons	Israel Lowy,

Title	BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo® (cemiplimab) Combination in NSCLC
Media name/outlet	PipelineReview
Country/Territory	Spain
Date	9/03/22
URL	ct.moreover.com/?a=47217714550&p=1gw&v=1&x=51n9fyEbgT5WlnuRQ1chWQ
Persons	Israel Lowy,

Title	BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo® (cemiplimab) Combination in NSCLC
Media name/outlet	MENAFN -Press Releases (English)
Country/Territory	Jordan
Date	8/03/22
Persons	Israel Lowy,

Title	BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo® (cemiplimab) Combination in NSCLC
Media name/outlet	Morningstar.com
Country/Territory	United States
Date	8/03/22
URL	ct.moreover.com/?a=47210352095&p=1gw&v=1&x=Yn69NnRftuIqpaPOwpKcpg
Persons	Israel Lowy,

Title	BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo® (cemiplimab) Combination in NSCLC
Media name/outlet	Street Insider
Country/Territory	United States
Date	8/03/22
URL	ct.moreover.com/?a=47210298809&p=1gw&v=1&x=YDyvCMiAGKJ_Dn_68R6M9w
Persons	Israel Lowy,

Title	BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo® (cemiplimab) Combination in NSCLC
Media name/outlet	TMC Net
Country/Territory	United States
Date	8/03/22
URL	ct.moreover.com/?a=47210327033&p=1gw&v=1&x=jdrQ6WtjoHDRGFhkA7mTEg
Persons	Israel Lowy,

Title	BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo® (cemiplimab) Combination in NSCLC
Media name/outlet	BioSpace
Country/Territory	United States
Date	8/03/22
URL	ct.moreover.com/?a=47212062832&p=1gw&v=1&x=rUu97qPta098i5arTBfcIA
Persons	Israel Lowy,

Title	BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo® (cemiplimab) Combination in NSCLC
Media name/outlet	Finanzen.net
Country/Territory	Germany
Date	8/03/22
URL	ct.moreover.com/?a=47210313939&p=1gw&v=1&x=veW0oaaUkS_qVcDhGuxqMQ
Persons	Israel Lowy,

Title	BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo® (cemiplimab) Combination in NSCLC
Media name/outlet	Yahoo! Finance
Country/Territory	United States
Date	8/03/22
URL	ct.moreover.com/?a=47210380518&p=1gw&v=1&x=8Z1JuJT8OsETY06Q9mZJsg
Persons	Israel Lowy,

Title	BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo® (cemiplimab) Combination in NSCLC
Media name/outlet	ADVFN UK
Country/Territory	United Kingdom
Date	8/03/22
URL	ct.moreover.com/?a=47210353466&p=1gw&v=1&x=BYiYnNmlR-FfN1NRk-KEcA
Persons	Israel Lowy,

Title	BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo® (cemiplimab) Combination in NSCLC
Media name/outlet	Finanzen.ch
Country/Territory	Switzerland
Date	8/03/22
URL	ct.moreover.com/?a=47210389437&p=1gw&v=1&x=x1RVI534BQBfq6pqeAA9NA
Persons	Israel Lowy,

Title	BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo® (cemiplimab) Combination in NSCLC
Media name/outlet	MarketScreener.com
Country/Territory	United States
Date	8/03/22
URL	ct.moreover.com/?a=47210302938&p=1gw&v=1&x=72NnVoVvTMbY-9TKVNAfcg
Persons	Israel Lowy,

Title	BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo® (cemiplimab) Combination in NSCLC
Media name/outlet	Crwe World
Country/Territory	United States
Date	8/03/22
URL	ct.moreover.com/?a=47210311562&p=1gw&v=1&x=cGc68L3EkLZovHzSfdx6zw
Persons	Israel Lowy,

Title	BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo® (cemiplimab) Combination in NSCLC
Media name/outlet	Spoke.com
Country/Territory	United States
Date	8/03/22
URL	ct.moreover.com/?a=47210486380&p=1gw&v=1&x=mJTE9zBPoh7s9iGiBdIRCw
Persons	Israel Lowy,

Title	BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo® (cemiplimab) Combination in NSCLC
Media name/outlet	GlobeNewswire
Country/Territory	United States
Date	8/03/22
URL	ct.moreover.com/?a=47210305696&p=1gw&v=1&x=mUV0YcQ2R6318Bo3ZqCTQg
Persons	Israel Lowy,

Title	BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo® (cemiplimab) Combination in NSCLC
Media name/outlet	PrimeNewswire (Top News)
Country/Territory	United States
Date	8/03/22
Persons	Israel Lowy,

Title	BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo® (cemiplimab) Combination in NSCLC
Media name/outlet	Investegate
Country/Territory	United Kingdom
Date	8/03/22
URL	ct.moreover.com/?a=47210313640&p=1gw&v=1&x=erxymNQE-gHvWFGeYgRKhA
Persons	Israel Lowy,

Title	BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo® (cemiplimab) Combination in NSCLC
Media name/outlet	BizWire Express
Country/Territory	India
Date	8/03/22
URL	ct.moreover.com/?a=47210468835&p=1gw&v=1&x=DHiXFS3QvoYpXd3wgLT8LQ
Persons	Israel Lowy,

Title	BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo® (cemiplimab) Combination in NSCLC
Media name/outlet	BioNTech
Country/Territory	Germany
Date	8/03/22
URL	ct.moreover.com/?a=47211433907&p=1gw&v=1&x=JxULxM7J7_lVkUNbeEcq0w
Persons	Israel Lowy,